Laboratoires Thea SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Laboratoires Thea SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013210
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratoires Thea SA (Thea) is an independent pharmaceutical company that researches, develops, manufactures, and commercializes a range of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, glaucoma, ocular and eyelid hygiene, eye surgery, and violations of the posterior segment. Its product portfolio includes eye drops, ophthalmic gels, sterile compresses, and micellar solutions. Thea markets these products under the brand names Blephagel, Blephasteam, Nutrof, ABAK, Blephasol and Blephaclean. The company markets its products through sales organizations and distributors on five continents. Thea is headquartered in Clermont Ferrand, Auvergne, France.

Laboratoires Thea SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratoires Thea SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratoires Thea SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Laboratoires Thea Acquires Rights To 19 Ophthalmic Products From Novartis 11
Partnerships 13
Labtician Ophthalmics forms Joint Venture with Laboratoires Thea 13
Pierre Fabre Enters into Co-Promotion Agreement with Laboratoires Thea 14
Acquisition 15
Laboratoires Thea Acquires Spectrum Thea Pharma 15
Laboratoires Thea SA – Key Competitors 16
Laboratoires Thea SA – Key Employees 17
Laboratoires Thea SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratoires Thea SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratoires Thea SA, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratoires Thea SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratoires Thea SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratoires Thea Acquires Rights To 19 Ophthalmic Products From Novartis 11
Labtician Ophthalmics forms Joint Venture with Laboratoires Thea 13
Pierre Fabre Enters into Co-Promotion Agreement with Laboratoires Thea 14
Laboratoires Thea Acquires Spectrum Thea Pharma 15
Laboratoires Thea SA, Key Competitors 16
Laboratoires Thea SA, Key Employees 17
Laboratoires Thea SA, Subsidiaries 18
Laboratoires Thea SA, Joint Venture 19

★海外企業調査レポート[Laboratoires Thea SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tyson Fresh Meats Inc:企業の戦略・SWOT・財務情報
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nativis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. The company provides portfolio of pipeline candidates which are under development for various therapeutic areas such as recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma, among oth …
  • Rohto Pharmaceutical Co Ltd (4527):企業の財務・戦略的SWOT分析
    Summary Rohto Pharmaceutical Co Ltd (Rohto Pharmaceutical) is a pharmaceutical company that manufactures and markets cosmetics and functional foods. The company offers products such as eye care products, skin care products, oral medicine product, cosmetics, eye drops, gastrointestinal medicines, der …
  • Gazprom (GAZP):石油・ガス:M&Aディール及び事業提携情報
    Summary Gazprom is an integrated global oil and gas company. It carries out the exploration, production, transportation, storage, processing and marketing of natural gas, gas condensate and crude oil. The company also sells gas as a vehicle fuel and participates in the generation and marketing of he …
  • PT Perusahaan Listrik Negara (Persero) Tbk:戦略・SWOT・企業財務分析
    PT Perusahaan Listrik Negara (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Perusahaan Listrik Negara (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Rolls-Royce Holdings Plc:企業のM&A・事業提携・投資動向
    Rolls-Royce Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rolls-Royce Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Helen of Troy Ltd:企業の戦略・SWOT・財務情報
    Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report Summary Helen of Troy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BSN medical GmbH:医療機器:M&Aディール及び事業提携情報
    Summary BSN medical GmbH (BSN medical), a subsidiary of Essity Aktiebolag, is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases and lumphology, and non-invasive orthopedic produ …
  • Galilee Energy Ltd (GLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Galilee Energy Ltd (Galilee) is a mining and minerals exploration and development company that offers exploration and development services. The company acquires, explores, produces, and develops coal seam gas in the Galilee Basin near Longreach in Queensland. It offers projects such as ATP79 …
  • Briggs & Stratton Corporation:企業の戦略・SWOT・財務分析
    Briggs & Stratton Corporation - Strategy, SWOT and Corporate Finance Report Summary Briggs & Stratton Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AnaBios Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization that offers drug efficacy studies on human samples. The organization’s products portfolio includes human dorsal root ganglia neuron cultures, human cardiac mesenchymal stem cells, human heart tissue samples, human …
  • Onex Corporation:企業の戦略・SWOT・財務情報
    Onex Corporation - Strategy, SWOT and Corporate Finance Report Summary Onex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fujitsu Limited (6702):企業の財務・戦略的SWOT分析
    Fujitsu Limited (6702) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Citizens Electric Corporation:企業の発電所・SWOT分析2018
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Covalon Technologies Ltd (COV):企業の財務・戦略的SWOT分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen m …
  • Nielsen Holdings PLC:企業のM&A・事業提携・投資動向
    Nielsen Holdings PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nielsen Holdings PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Axalta Coating Systems Ltd:企業の戦略・SWOT・財務情報
    Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆